Overall, Dicer expression in cell lines recapitulated the observed deregulation in clinical specimens, confirming higher Dicer immunostaining in melanomas when compared to melanocytic nevi or carcinomas of the skin (Figs. 1, 2 and 3). The gene discussed is DICER1; the disease is melanoma.